Expert Opinion on Biological Therapy, Volume 23, Issue 12 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 23, Issue 12 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
What future do biological therapies have in the treatment of gout?
Lisa K Stamp & Angelo Gaffo
Pages: 1151-1154
Published online: 03 Nov 2023
First Page PreviewforWhat future do biological therapies have in the treatment of gout? | Full Text | References | PDF (1.1 MB) | EPUB
  • 703 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
What role can LAG-3-blocking antibodies play in melanoma therapy?
Piotr Rutkowski & Paulina Jagodzińska-Mucha
Pages: 1155-1158
Published online: 10 Nov 2023
First Page PreviewforWhat role can LAG-3-blocking antibodies play in melanoma therapy? | Full Text | References | PDF (202.5 KB) | EPUB | Supplemental
  • 619 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?
Marta Loredo, Ignacio Braña & Rubén Queiro
Pages: 1159-1162
Published online: 24 Oct 2023
First Page PreviewforDoes pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients? | Full Text | References | PDF (683.5 KB) | EPUB
  • 1120 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Review Article
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis
Alexandria Matic, Nouf Alfaidi & Vera Bril
Pages: 1163-1171
Published online: 25 Dec 2023
AbstractforAn evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis | Full Text | References | PDF (1.5 MB) | EPUB
  • 203 Views
  • 2 CrossRef citations
  • 0Altmetric
Review Article
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)
Tro Sekayan, Dana H. Simmons & Annette von Drygalski
Pages: 1173-1184
Published online: 23 Nov 2023
AbstractforEtranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency) | Full Text | References | PDF (662.9 KB) | EPUB
  • 1620 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Drug evaluation

Review Article
Anacaulase-bcdb for the treatment of severe thermal burns
Yaron Shoham, Yuval Krieger & Jeremy Goverman
Pages: 1185-1191
Published online: 24 Oct 2023
AbstractforAnacaulase-bcdb for the treatment of severe thermal burns | Full Text | References | PDF (2.9 MB) | EPUB
  • 125 Views
  • 0 CrossRef citations
  • 0Altmetric

Meeting Report

Meeting Report
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting
Xingchen Li, Peng Zhang, Hao Sun, Lijie Han, Zhongxing Jiang & Jifeng Yu
Pages: 1193-1195
Published online: 26 Oct 2023
AbstractforBispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting | Full Text | References | PDF (171.5 KB) | EPUB
  • 365 Views
  • 0 CrossRef citations
  • 0Altmetric

Special Report

Report
The history of Crohn’s perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel
Damian García-Olmo & Mariano Garcia-Arranz
Pages: 1197-1202
Published online: 22 Nov 2023
AbstractforThe history of Crohn’s perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel | Full Text | References | PDF (608.6 KB) | EPUB
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric

Perspective

Comment
Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway
Guro L Goll & Tore K Kvien
Pages: 1203-1209
Published online: 01 Nov 2023
AbstractforImproving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway | Full Text | References | PDF (1.7 MB) | EPUB
  • 551 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Comment
Intravenous immunoglobulin as a potential treatment for long COVID
Matthew W. McCarthy
Pages: 1211-1217
Published online: 18 Dec 2023
AbstractforIntravenous immunoglobulin as a potential treatment for long COVID | Full Text | References | PDF (314.7 KB) | EPUB
  • 190 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Biological therapies for the treatment of psoriasis in pediatrics
Mariam Nikolaishvili & Vito Di Lernia
Pages: 1219-1226
Published online: 10 Nov 2023
AbstractforBiological therapies for the treatment of psoriasis in pediatrics | Full Text | References | PDF (282.9 KB) | EPUB
  • 135 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Antibody based therapeutics for autoimmune hemolytic anemia
Francesca Cavallaro, Wilma Barcellini & Bruno Fattizzo
Pages: 1227-1237
Published online: 01 Nov 2023
AbstractforAntibody based therapeutics for autoimmune hemolytic anemia | Full Text | References | PDF (1.4 MB) | EPUB
  • 2774 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
Jacopo Simonetti, Giacomo Sgalla & Luca Richeldi
Pages: 1239-1244
Published online: 10 Oct 2023
AbstractforAn up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis | Full Text | References | PDF (249 KB) | EPUB
  • 320 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Bulevirtide and emerging drugs for the treatment of hepatitis D
Helen Y Xu, Jamie O Yang, Phillip H Chen & Steven-Huy B Han
Pages: 1245-1253
Published online: 31 Oct 2023
AbstractforBulevirtide and emerging drugs for the treatment of hepatitis D | Full Text | References | PDF (1.3 MB) | EPUB
  • 136 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Biological therapy in polymyalgia rheumatica
Daniel Wendling
Pages: 1255-1263
Published online: 23 Nov 2023
AbstractforBiological therapy in polymyalgia rheumatica | Full Text | References | PDF (306.9 KB) | EPUB
  • 317 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Adjuvant immunotherapy for locally advanced renal cell carcinoma
Michail Alevizakos & David McDermott
Pages: 1265-1275
Published online: 11 Dec 2023
AbstractforAdjuvant immunotherapy for locally advanced renal cell carcinoma | Full Text | References | PDF (323 KB) | EPUB
  • 153 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Integrating CAR-T cell therapy into the management of DLBCL: what we are learning
Massimo Martino, Filippo Antonio Canale, Gaetana Porto, Chiara Verduci, Giovanna Utano, Giorgia Policastro, Jessyca Germanò, Caterina Alati, Ludovica Santoro, Lucrezia Imbalzano & Martina Pitea
Pages: 1277-1285
Published online: 11 Dec 2023
AbstractforIntegrating CAR-T cell therapy into the management of DLBCL: what we are learning | Full Text | References | PDF (292.9 KB) | EPUB
  • 164 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Research

Article
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial
Hendrik Wessels, Oliver von Richter, Maria Velinova, Josef Höfler, Paul Chamberlain, Arno Kromminga, Dirk Lehnick & Karsten Roth
Pages: 1287-1297
Published online: 05 Dec 2023
AbstractforPharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial | Full Text | References | PDF (783.2 KB) | EPUB | Supplemental
  • 1689 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study
Taner Coşkuner, Şengül Çağlayan, Özlem Akgün, Rüya Torun, Emine Nur Sunar Yayla, İ̇lknur Bagrul, Gülşah Kılbaş, Gülçin Otar Yener, Hülya Köse, Kübra Öztürk, Özge Baba, Mustafa Çakan, Ferhat Demir, Hafize Emine Sönmez, Mukaddes Kalyoncu, Sara Sebnem Kılıç, Selçuk Yüksel, Esra Bağlan, Sevcan A Bakkaloğlu, Erbil Ünsal, Nuray Aktay Ayaz & Betül Sözeri
Pages: 1299-1306
Published online: 17 Nov 2023
AbstractforThe safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study | Full Text | References | PDF (346.8 KB) | EPUB
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
A Chiricozzi, SM Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, M Maurelli, M Galluzzo, M Munera Campos, T Seremet, G Caldarola, C De Simone, E Ippoliti, T Torres, S Gkalpakiotis, C Conrad, JM Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, AV Marzano, K Peris & MEDaCoTRA Study Group
Pages: 1307-1315
Published online: 18 Dec 2023
AbstractforCurrent treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study | Full Text | References | PDF (755.2 KB) | EPUB | Supplemental
  • 303 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London
Nik Kamperidis, Moulesh Shah, Sophie Young, Evgeniy Galimov, Shruti Sweeney & Naila Arebi
Pages: 1317-1329
Published online: 27 Nov 2023
AbstractforUse of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London | Full Text | References | PDF (578.4 KB) | EPUB | Supplemental
  • 865 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Understanding patient variability to biologic treatments in inflammatory bowel disease
Ahmad Z. Al Meslamani
Editorial | Published online: 26 May 2024
Free Access
Next-generation CD40 agonists for cancer immunotherapy
Hampus Andersson et al.
Review Article | Published online: 23 May 2024
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 22 May 2024
Could siRNA therapeutics change the way we treat dyslipidemia?
Peter E. Penson et al.
Editorial | Published online: 22 May 2024
Free Access
View all latest articles